Cargando…
Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis †
Background: The management of cT3 laryngeal cancers remains controversial, with studies recommending surgical or non-surgical approaches. Despite the many papers that have been published on the subject, there is a lack of studies showing which treatment has better results in terms of survival. Objec...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452463/ https://www.ncbi.nlm.nih.gov/pubmed/37626625 http://dx.doi.org/10.3390/biomedicines11082128 |
_version_ | 1785095677427056640 |
---|---|
author | Rao, Karthik Nagaraja Pai, Prathamesh S. Dange, Prajwal Kowalski, Luiz P. Strojan, Primož Mäkitie, Antti A. Guntinas-Lichius, Orlando Robbins, K. Thomas Rodrigo, Juan P. Eisbruch, Avraham Takes, Robert P. de Bree, Remco Coca-Pelaz, Andrés Piazza, Cesare Chiesa-Estomba, Carlos López, Fernando Saba, Nabil F. Rinaldo, Alessandra Ferlito, Alfio |
author_facet | Rao, Karthik Nagaraja Pai, Prathamesh S. Dange, Prajwal Kowalski, Luiz P. Strojan, Primož Mäkitie, Antti A. Guntinas-Lichius, Orlando Robbins, K. Thomas Rodrigo, Juan P. Eisbruch, Avraham Takes, Robert P. de Bree, Remco Coca-Pelaz, Andrés Piazza, Cesare Chiesa-Estomba, Carlos López, Fernando Saba, Nabil F. Rinaldo, Alessandra Ferlito, Alfio |
author_sort | Rao, Karthik Nagaraja |
collection | PubMed |
description | Background: The management of cT3 laryngeal cancers remains controversial, with studies recommending surgical or non-surgical approaches. Despite the many papers that have been published on the subject, there is a lack of studies showing which treatment has better results in terms of survival. Objective: To determine the difference in survival outcomes following total laryngectomy (TL), concurrent chemoradiation (CRT) or radiation therapy (RT) alone in T3 laryngeal cancers. Methods: Search of PubMed, Scopus, and Google Scholar databases from 1995 to 2023 employing specific keywords and Boolean operators to retrieve relevant articles. Statistical analysis was conducted using a random-effects model, and heterogeneity was evaluated using the Q-test and I(2) statistic. Funnel plot asymmetry was assessed using rank correlation and regression tests. Results: The qualitative data synthesis comprised 10,940 patients from 16 included studies. TL was performed in 2149 (19.4%), CRT in 6723 (61.5%), RT in 295 (2.7%), while non-surgical treatment was not specified in 1773 (16.2%) patients. The pooled 2-year overall survival (OS) rates were TL = 73%, CRT = 74.7%, RT = 57.9%, 3-year OS rates were TL = 64.3%, CRT = 62.9%, RT = 52.4%, and 5-year OS rates were TL = 54.2%, CRT = 52.7%, RT = 40.8%. There was a significant heterogeneity in the included studies. There was no statistically significant difference in 2-year OS (logOR= −0.88 (95% confidence interval (CI): −1.99 to 0.23), p = 0.12), 3-year OS (logOR = −0.6 (95% CI: −1.34 to 0.15), p = 0.11), and 5-year OS (logOR = −0.54 (95% CI: −1.29 to 0.21), p = 0.16) between TL and CRT. Instead, there was significant difference in 2-year OS (logOR= −1.2383 (95% CI: −2.1679 to −0.3087), p = 0.009), 3-year OS (−1.1262 (95% CI: −1.6166 to −0.6358), p < 0.001), and 5-year OS (−0.99 (95% CI: −1.44 to −0.53)), p < 0.001) between TL and RT alone. Conclusions and Significance: TL followed with adjuvant (chemo)radiation on indication and CRT with salvage surgery in reserve appear to have similar OS outcomes. Both resulted in better OS outcomes compared to RT alone in the treatment of T3 laryngeal cancers. If patients are unfit for chemotherapy, making CRT impossible, surgery may become the choice of treatment. |
format | Online Article Text |
id | pubmed-10452463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104524632023-08-26 Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis † Rao, Karthik Nagaraja Pai, Prathamesh S. Dange, Prajwal Kowalski, Luiz P. Strojan, Primož Mäkitie, Antti A. Guntinas-Lichius, Orlando Robbins, K. Thomas Rodrigo, Juan P. Eisbruch, Avraham Takes, Robert P. de Bree, Remco Coca-Pelaz, Andrés Piazza, Cesare Chiesa-Estomba, Carlos López, Fernando Saba, Nabil F. Rinaldo, Alessandra Ferlito, Alfio Biomedicines Review Background: The management of cT3 laryngeal cancers remains controversial, with studies recommending surgical or non-surgical approaches. Despite the many papers that have been published on the subject, there is a lack of studies showing which treatment has better results in terms of survival. Objective: To determine the difference in survival outcomes following total laryngectomy (TL), concurrent chemoradiation (CRT) or radiation therapy (RT) alone in T3 laryngeal cancers. Methods: Search of PubMed, Scopus, and Google Scholar databases from 1995 to 2023 employing specific keywords and Boolean operators to retrieve relevant articles. Statistical analysis was conducted using a random-effects model, and heterogeneity was evaluated using the Q-test and I(2) statistic. Funnel plot asymmetry was assessed using rank correlation and regression tests. Results: The qualitative data synthesis comprised 10,940 patients from 16 included studies. TL was performed in 2149 (19.4%), CRT in 6723 (61.5%), RT in 295 (2.7%), while non-surgical treatment was not specified in 1773 (16.2%) patients. The pooled 2-year overall survival (OS) rates were TL = 73%, CRT = 74.7%, RT = 57.9%, 3-year OS rates were TL = 64.3%, CRT = 62.9%, RT = 52.4%, and 5-year OS rates were TL = 54.2%, CRT = 52.7%, RT = 40.8%. There was a significant heterogeneity in the included studies. There was no statistically significant difference in 2-year OS (logOR= −0.88 (95% confidence interval (CI): −1.99 to 0.23), p = 0.12), 3-year OS (logOR = −0.6 (95% CI: −1.34 to 0.15), p = 0.11), and 5-year OS (logOR = −0.54 (95% CI: −1.29 to 0.21), p = 0.16) between TL and CRT. Instead, there was significant difference in 2-year OS (logOR= −1.2383 (95% CI: −2.1679 to −0.3087), p = 0.009), 3-year OS (−1.1262 (95% CI: −1.6166 to −0.6358), p < 0.001), and 5-year OS (−0.99 (95% CI: −1.44 to −0.53)), p < 0.001) between TL and RT alone. Conclusions and Significance: TL followed with adjuvant (chemo)radiation on indication and CRT with salvage surgery in reserve appear to have similar OS outcomes. Both resulted in better OS outcomes compared to RT alone in the treatment of T3 laryngeal cancers. If patients are unfit for chemotherapy, making CRT impossible, surgery may become the choice of treatment. MDPI 2023-07-28 /pmc/articles/PMC10452463/ /pubmed/37626625 http://dx.doi.org/10.3390/biomedicines11082128 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Rao, Karthik Nagaraja Pai, Prathamesh S. Dange, Prajwal Kowalski, Luiz P. Strojan, Primož Mäkitie, Antti A. Guntinas-Lichius, Orlando Robbins, K. Thomas Rodrigo, Juan P. Eisbruch, Avraham Takes, Robert P. de Bree, Remco Coca-Pelaz, Andrés Piazza, Cesare Chiesa-Estomba, Carlos López, Fernando Saba, Nabil F. Rinaldo, Alessandra Ferlito, Alfio Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis † |
title | Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis † |
title_full | Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis † |
title_fullStr | Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis † |
title_full_unstemmed | Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis † |
title_short | Survival Outcomes in T3 Laryngeal Cancers: Primary Total Laryngectomy vs. Concurrent Chemoradiation or Radiation Therapy—A Meta-Analysis † |
title_sort | survival outcomes in t3 laryngeal cancers: primary total laryngectomy vs. concurrent chemoradiation or radiation therapy—a meta-analysis † |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452463/ https://www.ncbi.nlm.nih.gov/pubmed/37626625 http://dx.doi.org/10.3390/biomedicines11082128 |
work_keys_str_mv | AT raokarthiknagaraja survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT paiprathameshs survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT dangeprajwal survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT kowalskiluizp survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT strojanprimoz survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT makitieanttia survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT guntinaslichiusorlando survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT robbinskthomas survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT rodrigojuanp survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT eisbruchavraham survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT takesrobertp survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT debreeremco survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT cocapelazandres survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT piazzacesare survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT chiesaestombacarlos survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT lopezfernando survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT sabanabilf survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT rinaldoalessandra survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis AT ferlitoalfio survivaloutcomesint3laryngealcancersprimarytotallaryngectomyvsconcurrentchemoradiationorradiationtherapyametaanalysis |